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+A: Introduction
The prevalence of obesity (BMI 30 kg/m 2 or more) has been increasing worldwide 1,2 . Bariatric surgery is the most effective treatment for morbid obesity 3 , resulting in a significant decrease in weight, as well as amelioration of associated co-morbidities including type 2 diabetes (T2DM) 4-6 , cardiovascular diseases 7 , obstructive sleep apnoea 8 and musculoskeletal disorders 9 .
A decrease in the number of co-morbidities may lead to a reduction in the healthcare resources associated with managing severe and complex obesity [10] [11] [12] .
Risk prediction models are based either on approximations of absolute probability, or the risk that a specific outcome can occur within a certain time period in a subject with an individual predictor profile (through the use of predictor variables (co-variables)) 13 .
Risk predictors include patient characteristics (such as age and sex), medical history, blood chemistry results and genetic markers. Predictors for diabetes resolution include the mode of diabetes control (diet, oral hypoglycaemic drugs, insulin), good glycaemic control, age at surgery, duration of diabetes and waist circumference 14, 15 .
Development of a multivariable prediction model requires a number of steps:
selecting a set of candidate predictors; identifying important predictors among them by regression analysis; specifying a model by assigning relative weights for each predictor in a combined risk calculator; estimating performance of the model by measuring model calibration and discrimination; and conducting internal validation to assess the potential for optimism and adjusting the model for overfitting when necessary 13 . Good models are usually derived from large observational studies.
Risk prediction models are used to guide clinicians and patients in a joint decision-making process for selection of appropriate treatments 16 . Accurate prognostic assessment may safeguard against putting patients in a high-risk situation and prevent an unnecessary economic burden on a healthcare system. To achieve this, prognostic models must be accurate and generalizable. Internal validation is not sufficient to confirm that a model which successfully predicts the outcome of interest is valuable or applicable to new individuals 17 .
Thus, external validation of derivation cohorts in new individuals is very important.
Calibration and discrimination are major evaluation methods for prediction models 13 . Calibration refers to the agreement between observed and predicted outcomes. It can be assessed graphically by plotting, or statistically by testing for goodness of fit 13 .
Discrimination refers to the ability to discriminate individuals with the outcome from those without it. Statistics commonly used to evaluate discrimination performance of prediction models include the concordance (or c) statistic, or area under the receiver operating characteristic (ROC) curve 18 .
Within an obese population, in the subgroup of diabetic patients, more patients indicated a cure of diabetes (58 per cent) as the most important outcome rather than weight loss (33 per cent). Understanding the potential benefits of surgery in relation to remission of diabetes may impact on the decision-making processes of patients and physicians.
The objective of this systematic review was to identify studies that have developed or validated risk prediction models for remission of T2DM after bariatric surgery and describe their performance.
+A: Methods

+B: Literature search and citation screening
A systematic literature search was performed in MEDLINE, MEDLINE-In-Process, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL). A detailed description of the search strategy used in each database, and the selection process as adapted from the conducted on 28 April 2015, and were restricted to full-text articles. There was no restriction on the timespan of the search.
Abstract screening was carried out by two reviewers. The evaluation of full-text publications was performed by a single reviewer using the inclusion and exclusion criteria provided below. A second reviewer checked the appropriateness of inclusion of studies.
Disagreements were resolved by consensus.
+B: Study selection
Studies were considered for inclusion based on the following criteria: intervention (bariatric surgery); type of study (observational studies, RCTs); predictive model (at least 2 risk factors or validation studies); outcomes reported (diabetes outcomes); language (English). Validation studies were included when the study validated the model in relation to the same outcome as reported in the derivation study.
+B: Data extraction and analysis
The following data from each included publication were extracted by one reviewer: population characteristics; intervention; selection of variables; number of subjects in the derivation or/and validation cohorts; source of the study population; utilization outcome; internal validation; model calibration; and discrimination.
+B: Assessment of model performance
Data related to discrimination (the ability of a model to recognize individuals who experience the outcome from those who do not) and calibration (agreement between the model estimated outcome and the observed outcome) were abstracted. Discrimination was identified from the c-statistic, or area under the ROC curve (AUC) 13 ; an AUC of 0.500 suggested no discriminatory power, 0.501-0.699 poor discriminatory power, 0.700 to 0.799 acceptable discriminatory power, 0.800-0.899 excellent discriminatory power, and 0.900 indicated outstanding discriminatory power 20, 21 . Model calibration was identified from Hosmer-Lemeshow tests or correlation coefficients for each study 13 .
+A: Results
The search strategy yielded 2330 citations. Of these, 102 studies were eligible for full-text review and eight studies, evaluating six risk prediction models, were selected ( Fig. 1 ). Articles excluded with reasons for exclusion are shown in Table S1 (supporting information). All models focused on prediction of remission of T2DM. Among the six published risk prediction models, two were validated in one or more independent cohorts 22, 23 . Among the remaining four models, one was internally validated (by 10-fold validation method 24 ), whereas the remaining models
were not validated [25] [26] [27] . 
+B: Risk prediction models validated in at least one independent cohort
The Diabetes Surgery score (ABCD score) 22 and diabetes remission (DiaRem) score 23 were both validated in one or more independent cohorts.
+C: ABCD score
The ABCD score includes four categorical variables to predict remission of T2DM: BMI, Cpeptide, T2DM duration and age). The ABCD score ranges from 0 to 10 points by summing the points for each variable, with high scores indicating a greater chance of remission 22 . The ABCD score was derived from a multicentre cohort including 63 patients who had a BMI of at least 35 kg/m 2 , or a BMI below 35 kg/m 2 but with poorly controlled T2DM, and who had undergone laparoscopic gastric bypass for uncontrolled T2DM. Patient follow-up in the derivation cohort was at least 3 years. Internal validation was not performed in the derivation cohort.
The model has been validated in three independent cohorts, including a total of 341 patients who underwent bariatric surgery 22, 28, 29 , using the outcome T2DM remission at 1 year after surgery. The validation cohorts were mainly from the same institutions as the derivation cohort, but at a later time. Three cohorts consisted of patients with a mean age ranging from 42 to 48 years, 48-64 per cent females, a BMI between 26.9 and 39.0 kg/m 2 , and a T2DM duration ranging from 2.4 to 6.5 years before the surgery. Patients underwent either laparoscopic gastric bypass (Roux-en-Y gastric bypass, LYGB) or laparoscopic sleeve gastrectomy.
Model calibration or discrimination was not reported in either the derivation or validation cohorts.
+B: DiaRem score
The DiaRem score was developed to predict remission of T2DM after RYGB 23 Model calibration or discrimination was not reported in either the derivation or validation cohorts.
+B: Risk prediction models without validation in independent cohorts
There were four models without external cohort validation [24] [25] [26] [27] . 
+A: Discussion
This systematic review identified and evaluated six risk prediction models for diabetes outcomes after bariatric surgery. Only two models (ABCD score 22 and DiaRem score 23 This can be tested by means of calibration analysis, which can be assessed either visually (how close the predicted and observed values are) or with specific tests. Miscalibrated models may lead to the situation where a patient with a high chance of remission is actually assigned to a low chance of remission, thereby leading to a biased interpretation of the benefits of surgery.
Reporting both calibration and discrimination is a standard step in evaluating the performance of risk prediction models 30 .
In the model of Dixon and colleagues 25 , the AUC was 0.69 (inadequate), meaning that only in 69 per cent of random cases would a score indicating higher chances of remission actually be higher in patients who experienced remission than in patients with no remission.
Outstanding discriminative ability was demonstrated (AUC 0.950) for the model of Robert et al. 27 . The five variables in this are BMI, duration of diabetes, HbA1c level, concentration of fasting glucose and oral antidiabetic drugs.
Models were developed for different patient groups. The diabetes remission score proposed by Ugale and colleagues 26 , and the model by Dixon et al. 25 were developed from analysis of patients with a BMI below 30 kg/m 2 , and a long history of diabetes (8-10 years).
All other models [22] [23] [24] [27] [28] [29] originally included patients with a much higher BMI (39-50 kg/m 2 ) and a shorter duration of diabetes (3-5 years). The surgery types were mainly gastric bypass and sleeve gastrectomy. The ABCD score was developed from a cohort of patients who underwent gastric bypass 22 . It was validated in two cohorts: one with gastric bypass and the other including both bypass and sleeve gastrectomy 28, 29 Output format can also be important for ease of use of models in clinical practice.
The ABCD score 22 , DiaRem score 23 , the diabetes remission score proposed by Ugale and colleagues 26 and the algorithm proposed by Robert et al. 27 are risk calculator scores. Therefore, the output of each model is a value at a point along a predefined scale. Scores might be less intuitive than risk or chances of remission, and may require extensive use to allow easy day-today interpretation of the results in relation to an individual patient's prognosis. Hayes and colleagues 24 proposed two formulas to determine whether a patient is likely to recover from diabetes if the value in one formula ('class resolved') is higher than that in the other ('class not resolved'). Dixon and co-workers 25 proposed a simple formula to calculate the likelihood of remission.
All published risk prediction models have limitations in quality and further validation is required. They still might be of relevance for clinical practice. The type of surgery, patient population, output format, and availability of inputs to physician and patients can all influence the choice of model. Limitations of each model need to be evaluated, acknowledged and considered before implementation into clinical practice. The optimal management of bariatric surgery requires accurate assessment of prognosis, and this is still challenging.
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